07.27.20 -- How Heat Bio Was Built Around Its Therapeutic Platform
Product Characterization Packages Designed To Speed Time To Actionable Data
Our comprehensive program reveals the true identity of your molecule through every phase of development, ensuring your biotherapy’s safety, purity, and potency. Select from one of our mAb-based assay packages or a custom assay tailored to your biologic.
The procedures outlined in the newly published HBEL standard are expected to greatly aid professionals in the derivation of acceptable levels of carryover and should be used in the risk assessment of cleaning processes using the ASTM E3106 Standard Guide for Science Based and Risk Based Cleaning Process Development and Validation.
With the science behind the Heat Biologics platform to activate immune responses against pathogenic or cancer antigens in place, founder and CEO Jeff Wolf proceeded to structure the organization in a strategic fashion to support that platform. On this episode of Business Of Biotech – Summer Executive Sessions, Wolf tells us how he did it.
White Paper |
By Davy De Wilde, Joerg Weyand, et al.,Sartorius Stedim Biotech
Single-use bioreactors address some key challenges the industry faces by decreasing time-to-market, reducing validation efforts, increasing flexibility, reducing investment costs, and optimizing cost of goods.
Dr. Ben Zeskind founded Immuneering in 2008 as the economy spiraled into the Great Recession. Here, Zeskind tells us how he adjusted his fundraising strategy to build the foundation of a thriving company.